RT Journal Article SR Electronic T1 Scleral growth stunting via sub-Tenon injection of cross-linking solutions in live rabbits JF British Journal of Ophthalmology JO Br J Ophthalmol FD BMJ Publishing Group Ltd. SP 889 OP 894 DO 10.1136/bjophthalmol-2021-319427 VO 107 IS 6 A1 Hoang, Quan V A1 Wen, Quan A1 Paik, David C A1 Chun, Yong Yao A1 Silverman, Ronald A1 Nagasaki, Takayuki A1 Trokel, Stephen L A1 Zyablitskaya, Mariya YR 2023 UL http://bjo.bmj.com/content/107/6/889.abstract AB Background Scleral cross-linking is a potential method to inhibit axial elongation of the eye, preventing the progression of pathological myopia. Formaldehyde releasers, which are common preservatives found in cosmetics and ophthalmic solutions, have been shown to be not only effective in cross-linking corneal collagen in vitro and in vivo, but also have minimal toxicity effects on the eye. The present study aims to evaluate the efficacy of scleral cross-linking using sodium hydroxymethylglycinate (SMG) to inhibit eye growth using an in vivo rabbit model.Methods A cross-linking solution containing 40 mM SMG was delivered to the sub-Tenon’s space behind the equator. The application regimen included a two-quadrant injection performed five times over 2 weeks on New Zealand White rabbits (n=5, group 1), and one-time injection followed for up to 5 days on Dutch-Belted rabbits (n=6, group 2). Group 1 was monitored serially for axial length changes using B-scan ultrasound for 5–6 weeks. Group 2 was injected with a higher viscosity solution formulation. Both groups were evaluated for thermal denaturation temperature changes of the sclera postmortem.Results Axial growth was limited by 10%–20% following SMG treatment as compared with the untreated eye. Thermal denaturation analysis showed increased heat resistance of the treated eyes in the areas of injection. Overall, the SMG treatment inhibited eye growth with few side effects from the injections.Conclusions Cross-linking solutions delivered via sub-Tenon injection provide a potential method for limiting axial length growth in progressive myopia and could be used as a potential treatment for myopia.Data are available upon reasonable request. Data are available upon reasonable request from corresponding authors.